Innovation in the production process of veterinary vaccines against leptospirosis and borreliosis (Q9935)

From EU Knowledge Graph
Revision as of 12:07, 13 February 2020 by DG Regio (talk | contribs) (‎Changed an Item: Label in wikidata changed)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Innovation in the production process of veterinary vaccines against leptospirosis and borreliosis
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    7,500,000.0 Czech koruna
    0 references
    300,000.0 Euro
    10 January 2020
    0 references
    30,000,000.0 Czech koruna
    0 references
    1,200,000.0 Euro
    10 January 2020
    0 references
    25 percent
    0 references
    19 November 2015
    0 references
    23 August 2018
    0 references
    1 October 2018
    0 references
    Bioveta, a.s.
    0 references
    0 references

    49°18'9.65"N, 17°4'54.52"E
    0 references

    49°17'53.88"N, 17°6'21.31"E
    0 references
    68323
    0 references
    Předmětem projektu je inovace procesu výroby a kultivace vakcín proti leptospiróze a borelióze založená na pomnožení spirochet fermentační kultivací v průmyslovém bioreaktoru. Inovace procesu bude realizována formou zavedení nové technologie výroby antigenů. Inovace se týká celé řady přípravků (např. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). V rámci projektu bude pořízena technologie pro nový způsob výroby, a to bioreaktory, formulační kotel a ultrafiltr. a. (Czech)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/15_014/0004382
    0 references